Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth E Dickenson

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Frontiers in Cellular and Infection Microbiology|March 29, 2021
Interferons: Tug of War Between Bacteria and Their HostNoémie Alphonse, Ruth E Dickenson, Charlotte Odendall
Frontiers in Immunology|June 6, 2022
Functions of IFNλs in Anti-Bacterial Immunity at Mucosal BarriersNoémie Alphonse, Ruth E Dickenson, Abrar Alrehaili, et al.
Virulence|December 5, 2024
EGR1 regulates oral epithelial cell responses to <i>Candida albicans</i> via the EGFR- ERK1/2 pathwayRuth E Dickenson, Aize Pellon, Nicole O Ponde, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
EGR1 regulates oral epithelial cell responses to <i>Candida albicans</i> via the EGFR- ERK1/2 pathwayRuth E Dickenson, Aize Pellon, Nicole O Ponde, et al.
The Journal of Experimental Medicine|April 15, 2020
COVID-19 and emerging viral infections: The case for interferon lambdaLudmila Prokunina-Olsson, Noémie Alphonse, Ruth E Dickenson, et al.
Cell|May 14, 2022
A family of conserved bacterial virulence factors dampens interferon responses by blocking calcium signalingNoémie Alphonse, Joseph J Wanford, Andrew A Voak, et al.
The Journal of Infection|October 17, 2020
Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE EnglandPhilippa M Wells, Katie J Doores, Simon Couvreur, et al.
Medrxiv : the Preprint Server for Health Sciences|June 15, 2021
Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B.1.1.7 infectionsLiane Dupont, Luke B Snell, Carl Graham, et al.
Nature Microbiology|October 16, 2021
Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concernLiane Dupont, Luke B Snell, Carl Graham, et al.
Plos One|September 15, 2021
Resilient SARS-CoV-2 diagnostics workflows including viral heat inactivationMaria Jose Lista, Pedro M Matos, Thomas J A Maguire, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Frontiers in Cellular and Infection Microbiology|March 29, 2021
Interferons: Tug of War Between Bacteria and Their HostNoémie Alphonse, Ruth E Dickenson, Charlotte Odendall
Frontiers in Immunology|June 6, 2022
Functions of IFNλs in Anti-Bacterial Immunity at Mucosal BarriersNoémie Alphonse, Ruth E Dickenson, Abrar Alrehaili, et al.
Virulence|December 5, 2024
EGR1 regulates oral epithelial cell responses to <i>Candida albicans</i> via the EGFR- ERK1/2 pathwayRuth E Dickenson, Aize Pellon, Nicole O Ponde, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
EGR1 regulates oral epithelial cell responses to <i>Candida albicans</i> via the EGFR- ERK1/2 pathwayRuth E Dickenson, Aize Pellon, Nicole O Ponde, et al.
The Journal of Experimental Medicine|April 15, 2020
COVID-19 and emerging viral infections: The case for interferon lambdaLudmila Prokunina-Olsson, Noémie Alphonse, Ruth E Dickenson, et al.
Cell|May 14, 2022
A family of conserved bacterial virulence factors dampens interferon responses by blocking calcium signalingNoémie Alphonse, Joseph J Wanford, Andrew A Voak, et al.
The Journal of Infection|October 17, 2020
Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE EnglandPhilippa M Wells, Katie J Doores, Simon Couvreur, et al.
Medrxiv : the Preprint Server for Health Sciences|June 15, 2021
Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B.1.1.7 infectionsLiane Dupont, Luke B Snell, Carl Graham, et al.
Nature Microbiology|October 16, 2021
Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concernLiane Dupont, Luke B Snell, Carl Graham, et al.
Plos One|September 15, 2021
Resilient SARS-CoV-2 diagnostics workflows including viral heat inactivationMaria Jose Lista, Pedro M Matos, Thomas J A Maguire, et al.
Pageof 2